EPISODE · May 15, 2026 · 1 MIN
Vdyne Granted FDA IDE For Tricuspid Valve Replacement Study
from TheBrief.Health · host TheBrief.Health
Vdyne’s investigational transcatheter tricuspid valve replacement device advances less invasive treatment for severe tricuspid regurgitation, potentially improving heart failure outcomes in high-risk patients.
What this episode covers
Vdyne’s investigational transcatheter tricuspid valve replacement device advances less invasive treatment for severe tricuspid regurgitation, potentially improving heart failure outcomes in high-risk patients.
NOW PLAYING
Vdyne Granted FDA IDE For Tricuspid Valve Replacement Study
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m